Trajectory and predictors of HbA1c in children and adolescents with type 1 diabetes-A Danish nationwide cohort study.


Journal

Pediatric diabetes
ISSN: 1399-5448
Titre abrégé: Pediatr Diabetes
Pays: Denmark
ID NLM: 100939345

Informations de publication

Date de publication:
09 2022
Historique:
revised: 21 02 2022
received: 26 08 2021
accepted: 28 03 2022
pubmed: 3 4 2022
medline: 10 8 2022
entrez: 2 4 2022
Statut: ppublish

Résumé

Poor glycemic control in type 1 diabetes increases the risk of chronic complications and it is essential to identify life periods and predictors associated with deteriorating HbA 5889 children with type 1 diabetes were included from the nationwide Danish Registry of Childhood and Adolescent Diabetes with annual visits during 1996-2019. Trajectories of HbA HbA Glycemic outcome worsened with age during childhood and adolescence, which is of clinical concern. Important predictors for a poorer glycemic trajectory were later age at diabetes diagnosis, shorter parental education, non-Danish origin and, in particular low BGM frequency.

Identifiants

pubmed: 35366046
doi: 10.1111/pedi.13337
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin A 0
Hypoglycemic Agents 0
Insulin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

721-728

Informations de copyright

© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet (London, England). 2018;391(10138):2449-2462.
Patterson CC, Harjutsalo V, Rosenbauer J, et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study. Diabetologia. 2019;62(3):408-417.
Patterson CC, Karuranga S, Salpea P, et al. Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107842.
Anderzen J, Samuelsson U, Gudbjornsdottir S, Hanberger L, Akesson K. Teenagers with poor metabolic control already have a higher risk of microvascular complications as young adults. J Diabetes Complications. 2016;30(3):533-536. https://pubmed.ncbi.nlm.nih.gov/26775554/
Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371(21):1972-1982.
White M, Sabin MA, Magnussen CG, O'Connell MA, Colman PG, Cameron F. Long term risk of severe retinopathy in childhood-onset type 1 diabetes: a data linkage study. Med J Aust. 2017;206(9):398-401.
Anderzén J, Hermann JM, Samuelsson U, et al. International benchmarking in type 1 diabetes: large difference in childhood HbA1c between eight high-income countries but similar rise during adolescence-A quality registry study. Pediatr Diabetes. 2020;21(4):621-627.
Borus JS, Laffel L. Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr. 2010;22(4):405-411.
Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72.
McKnight JA, Wild SH, Lamb MJ, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015;32(8):1036-1050.
Miller KM, Foster NC, Beck RW, et al. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D exchange clinic registry. Diabetes Care. 2015;38(6):971-978.
Schwandt A, Hermann JM, Rosenbauer J, et al. Longitudinal trajectories of metabolic control from childhood to young adulthood in type 1 diabetes from a large German/Austrian registry: a group-based modeling approach. Diabetes Care. 2017;40(3):309-316.
Clements MA, Schwandt A, Donaghue KC, et al. Five heterogeneous HbA1c trajectories from childhood to adulthood in youth with type 1 diabetes from three different continents: a group-based modeling approach. Pediatr Diabetes. 2019;20:920-931.
Moore JM, Snell-Bergeon JK. Trajectories of hemoglobin A1c and body mass index z-score over four decades among 2 to 18 year olds with type 1 diabetes. Pediatr Diabetes. 2019;20(5):594-603.
Butalia S, Crawford SG, McGuire KA, Dyjur DK, Mercer JR, Pacaud D. Improved transition to adult care in youth with type 1 diabetes: a pragmatic clinical trial. Diabetologia. 2021;64(4):758-766.
Svensson J, Cerqueira C, Kjaersgaard P, et al. Danish registry of childhood and adolescent diabetes. Clin Epidemiol. 2016;8:679-683.
Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39(7 Suppl):91-94.
Clements MA, Foster NC, Maahs DM, et al. Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry. Pediatr Diabetes. 2016;17(5):327-336.
Hofer SE, Raile K, Frohlich-Reiterer E, et al. Tracking of metabolic control from childhood to young adulthood in type 1 diabetes. J Pediatr. 2014;165(5):956-961.e2.
Lawes T, Franklin V, Farmer G. HbA1c tracking and bio-psychosocial determinants of glycaemic control in children and adolescents with type 1 diabetes: retrospective cohort study and multilevel analysis. Pediatr Diabetes. 2014;15(5):372-383.
Pinhas-Hamiel O, Hamiel U, Boyko V, Graph-Barel C, Reichman B, Lerner-Geva L. Trajectories of HbA1c levels in children and youth with type 1 diabetes. PLoS One. 2014;9(10):e109109.
Wang JT, Wiebe DJ, White PC. Developmental trajectories of metabolic control among White, Black, and Hispanic youth with type 1 diabetes. J Pediatr. 2011;159(4):571-576.
Nielsen NF, Gaulke A, Eriksen TM, Svensson J, Skipper N. Socioeconomic inequality in metabolic control among children with type 1 diabetes: a nationwide longitudinal study of 4,079 Danish children. Diabetes Care. 2019;42(8):1398-1405.
Ibfelt EH, Vistisen D, Falberg Rønn P, et al. Associations between glycaemic outcomes and BMI in Danish children with type 1 diabetes in 2000-2018: a nationwide population-based study. Diabet Med. 2021;38(3):e14401. doi:10.1111/dme.14401
Luo M, Tan KHX, Tan CS, Lim WY, Tai ES, Venkataraman K. Longitudinal trends in HbA1c patterns and association with outcomes: a systematic review. Diabetes Metab Res Rev. 2018;34(6):e3015.
Birkebaek NH, Kristensen LJ, Mose AH, Thastum M. Quality of life in Danish children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections. Diabetes Res Clin Pract. 2014;106(3):474-480.
Rosner B, Roman-Urrestarazu A. Health-related quality of life in paediatric patients with type 1 diabetes mellitus using insulin infusion systems. A systematic review and meta-analysis. PLoS One. 2019;14(6):e0217655.
Mazarello Paes V, Barrett JK, Dunger DB, et al. Factors predicting poor glycemic control in the first two years of childhood onset type 1 diabetes in a cohort from East London, UK: analyses using mixed effects fractional polynomial models. Pediatr Diabetes. 2020;21(2):288-299.

Auteurs

Else Helene Ibfelt (EH)

Clinical Epidemiological Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Rasmus Wibaek (R)

Clinical Epidemiological Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Dorte Vistisen (D)

Clinical Epidemiological Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Gregers S Andersen (GS)

Clinical Epidemiological Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Marit E Jørgensen (ME)

Clinical Epidemiological Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark.
National Institute of Public Health, University of Southern Denmark, Odense, Denmark.

Adam Hulman (A)

Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.

Dana Dabelea (D)

Colorado School of Public Health, Aurora, Colorado, USA.

Niels H Birkebaek (NH)

Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark.
Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark.

Jannet Svensson (J)

Herlev and Gentofte University hospital, Herlev, Denmark.

Pernille F Rønn (PF)

Clinical Epidemiological Research, Steno Diabetes Center Copenhagen, Gentofte, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH